Trademark Overview

---

On Monday, December 7, 1998, a trademark application was filed for DENDRIVAX with the United States Patent and Trademark Office. The USPTO has given the DENDRIVAX trademark a serial number of 75600320. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, June 29, 2001. This trademark is owned by GeneMedicine, Inc.. The DENDRIVAX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical gene therapy compositions to target antigen presenting cells

General Information

---

Serial Number	75600320
Word Mark	DENDRIVAX
Filing Date	Monday, December 7, 1998
Status	606 - ABANDONED - NO STATEMENT OF USE FILED
Status Date	Friday, June 29, 2001
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, October 5, 1999

Trademark Statements

---

Goods and Services

pharmaceutical gene therapy compositions to target antigen presenting cells

Classification Information

---

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Saturday, January 30, 1999
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

---

Party Name	GeneMedicine, Inc.
Party Type	20 - Owner at Publication
Legal Entity Type	03 - Corporation
Address	The Woodlands, TX 778314248

---

Party Name	GeneMedicine, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	The Woodlands, TX 778314248

Trademark Events

---

Event Date	Event Description
Thursday, September 20, 2001	ABANDONMENT - NO USE STATEMENT FILED
Friday, February 9, 2001	EXTENSION 2 GRANTED
Monday, December 18, 2000	EXTENSION 2 FILED
Thursday, August 17, 2000	EXTENSION 1 GRANTED
Friday, June 23, 2000	EXTENSION 1 FILED
Tuesday, December 28, 1999	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 1999	PUBLISHED FOR OPPOSITION
Friday, September 3, 1999	NOTICE OF PUBLICATION
Thursday, July 1, 1999	APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 21, 1999	EXAMINER'S AMENDMENT MAILED
Tuesday, June 15, 1999	ASSIGNED TO EXAMINER

Related Keywords

---

dendrivax antigen presenting cells target compositions gene therapy pharmaceutical